Key statistics
On Wednesday, Iovance Biotherapeutics Inc (IOVA:NMQ) closed at 1.99, 21.45% above the 52 week low of 1.64 set on May 19, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.82 |
---|---|
High | 2.01 |
Low | 1.80 |
Bid | 1.98 |
Offer | 2.00 |
Previous close | 1.77 |
Average volume | 10.93m |
---|---|
Shares outstanding | 333.93m |
Free float | 276.56m |
P/E (TTM) | -- |
Market cap | 591.06m USD |
EPS (TTM) | -1.23 USD |
Data delayed at least 15 minutes, as of Jul 09 2025 21:00 BST.
More ▼
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Iovance Biotherapeutics to Present at Upcoming Conference
- The Journal of Clinical Oncology Publishes Five-year Analysis of Amtagvi® (lifileucel) in Patients with Advanced Melanoma
- Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Iovance Biotherapeutics Reports Financial Results and Corporate Updates for First Quarter 2025
- Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
- Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
More ▼